Pablo Pantaleoni - 06 Mar 2025 Form 4/A - Amendment Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Digital Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
06 Mar 2025
Net transactions value
-$483,794
Form type
4/A - Amendment
Filing time
17 Mar 2025, 16:30:11 UTC
Date Of Original Report
10 Mar 2025
Previous filing
19 Apr 2024
Next filing
12 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Award $0 +117,386 +16% $0.000000 859,228 06 Mar 2025 Direct F1
transaction LFST Common Stock Tax liability $153,219 -19,444 -2.3% $7.88 839,784 06 Mar 2025 Direct F2
transaction LFST Common Stock Award $0 +42,765 +5.1% $0.000000 882,549 07 Mar 2025 Direct F3
transaction LFST Common Stock Tax liability $110,867 -14,607 -1.7% $7.59 867,942 07 Mar 2025 Direct F4
transaction LFST Common Stock Award $0 +98,578 +11% $0.000000 966,520 07 Mar 2025 Direct F5
transaction LFST Common Stock Tax liability $219,708 -28,947 -3% $7.59 937,573 07 Mar 2025 Direct F6, F7
holding LFST Common Stock 558,085 06 Mar 2025 By Trust F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 117,386 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
F3 Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.
F4 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
F5 Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.
F6 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
F7 Reflects the direct beneficial ownership of the Reporting Person as of March 10, 2025.
F8 Reflects the indirect beneficial ownership of the Reporting Person as of March 10, 2025.
F9 Shares are held by the Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

Remarks:

On May 21, 2024, the Reporting Person assigned 558,085 shares to the Pablo Pantaleoni Garcia and Clara Zuazu Vela Joint Revocable Trust (the "Trust"), for which the Reporting Person and his spouse serve as the trustees and primary beneficiaries. This Form 4 is deemed to amend the number of shares reported as securities beneficially owned following reported transactions in Table I of the Form 4 filed by the Reporting Person on March 10, 2025 to reflect the assignment described in the following sentence. The Reporting Person assigned shares of common stock that were held by him directly to the Trust, but the Reporting Person continued to report all common stock beneficially owned by him directly.